# Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

> **NCT01674972** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 102 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis

## Interventions

- **OTHER:** Oral glucose tolerance test

## Key facts

- **NCT ID:** NCT01674972
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2012-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674972, "Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01674972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*